This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mittelstadt, P. R.
Right arrow Articles by Ashwell, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mittelstadt, P. R.
Right arrow Articles by Ashwell, J. D.

 Previous Article  |  Next Article 

Mol Cell Biol, July 1998, p. 3744-3751, Vol. 18, No. 7
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Cyclosporin A-Sensitive Transcription Factor Egr-3 Regulates Fas Ligand Expression

Paul R. Mittelstadt and Jonathan D. Ashwell*

Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1152

Received 3 February 1998/Returned for modification 16 March 1998/Accepted 3 April 1998

Activation-induced transcriptional upregulation of the ligand for Fas (FasL) and the resulting apoptosis of Fas-bearing cells constitute essential steps in a host of normal and pathological processes. Here we describe an activation-inducible cis-acting regulatory element in the fasL promoter that is required for gene expression. Oligonucleotide competition and antibody supershift analyses identified two activation-induced DNA-binding species: Egr-1 (NGFI-A, krox-24, zif268, TIS-8), a transcription factor that has been implicated in growth, differentiation, and apoptosis; and Egr-3 (PILOT), a transcription factor of no previously known function. Activation-induced expression of Egr-3, like that of FasL, was inhibited by cyclosporin A, whereas expression of Egr-1 was unaffected. Transient expression of Egr-3 alone increased fasL promoter activity in a cyclosporin A-insensitive manner, whereas expression of Egr-1 had little effect. Moreover, endogenous fasL mRNA was induced in nonlymphoid cells by forced expression of Egr-3 in the absence of any other stimulus. These studies identify a critical Egr family-binding site in the fasL promoter and demonstrate that activation-induced Egr-3, but not Egr-1, directly upregulates fasL transcription in response to activating stimuli.


* Corresponding author. Mailing address: Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bldg. 10, Room 1B-40, Bethesda, MD 20892-1152. Phone: (301) 496-4931. Fax: (301) 402-4844. E-mail: jda{at}Box-j.nih.gov.


Mol Cell Biol, July 1998, p. 3744-3751, Vol. 18, No. 7
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Tan, N. Y., Li, J.-M., Stocker, R., Khachigian, L. M. (2009). Angiotensin II-Inducible Smooth Muscle Cell Apoptosis Involves the Angiotensin II Type 2 Receptor, GATA-6 Activation, and FasL-Fas Engagement. Circ. Res. 105: 422-430 [Abstract] [Full Text]  
  • Iannello, A., Samarani, S., Debbeche, O., Ahmad, R., Boulassel, M.-R., Tremblay, C., Toma, E., Routy, J.-P., Ahmad, A. (2009). Potential Role of Interleukin-18 in the Immunopathogenesis of AIDS: Involvement in Fratricidal Killing of NK Cells. J. Virol. 83: 5999-6010 [Abstract] [Full Text]  
  • Fionda, C., Nappi, F., Piccoli, M., Frati, L., Santoni, A., Cippitelli, M. (2007). 15-Deoxy-{Delta}12,14-Prostaglandin J2 Negatively Regulates rankl Gene Expression in Activated T Lymphocytes: Role of NF-{kappa}B and Early Growth Response Transcription Factors. J. Immunol. 178: 4039-4050 [Abstract] [Full Text]  
  • Manicassamy, S., Sun, Z. (2007). The Critical Role of Protein Kinase C-{theta} in Fas/Fas Ligand-Mediated Apoptosis. J. Immunol. 178: 312-319 [Abstract] [Full Text]  
  • Collins, S., Wolfraim, L. A., Drake, C. G., Horton, M. R., Powell, J. D. (2006). Cutting Edge: TCR-Induced NAB2 Enhances T Cell Function by Coactivating IL-2 Transcription. J. Immunol. 177: 8301-8305 [Abstract] [Full Text]  
  • Castellano, R., Vire, B., Pion, M., Quivy, V., Olive, D., Hirsch, I., Van Lint, C., Collette, Y. (2006). Active Transcription of the Human FASL/CD95L/TNFSF6 Promoter Region in T Lymphocytes Involves Chromatin Remodeling: ROLE OF DNA METHYLATION AND PROTEIN ACETYLATION SUGGEST DISTINCT MECHANISMS OF TRANSCRIPTIONAL REPRESSION. J. Biol. Chem. 281: 14719-14728 [Abstract] [Full Text]  
  • Cippitelli, M., Fionda, C., Di Bona, D., Piccoli, M., Frati, L., Santoni, A. (2005). Hyperthermia Enhances CD95-Ligand Gene Expression in T Lymphocytes. J. Immunol. 174: 223-232 [Abstract] [Full Text]  
  • Xiao, S., Deshmukh, U. S., Jodo, S., Koike, T., Sharma, R., Furusaki, A., Sung, S.-s. J., Ju, S.-T. (2004). Novel Negative Regulator of Expression in Fas Ligand (CD178) Cytoplasmic Tail: Evidence for Translational Regulation and against Fas Ligand Retention in Secretory Lysosomes. J. Immunol. 173: 5095-5102 [Abstract] [Full Text]  
  • Torgler, R., Jakob, S., Ontsouka, E., Nachbur, U., Mueller, C., Green, D. R., Brunner, T. (2004). Regulation of Activation-induced Fas (CD95/Apo-1) Ligand Expression in T Cells by the Cyclin B1/Cdk1 Complex. J. Biol. Chem. 279: 37334-37342 [Abstract] [Full Text]  
  • Yasunaga, J.-i., Taniguchi, Y., Nosaka, K., Yoshida, M., Satou, Y., Sakai, T., Mitsuya, H., Matsuoka, M. (2004). Identification of Aberrantly Methylated Genes in Association with Adult T-Cell Leukemia. Cancer Res. 64: 6002-6009 [Abstract] [Full Text]  
  • Yoo, Y.-G., Lee, M.-O. (2004). Hepatitis B Virus X Protein Induces Expression of Fas Ligand Gene through Enhancing Transcriptional Activity of Early Growth Response Factor. J. Biol. Chem. 279: 36242-36249 [Abstract] [Full Text]  
  • Xi, H., Kersh, G. J. (2004). Sustained Early Growth Response Gene 3 Expression Inhibits the Survival of CD4/CD8 Double-Positive Thymocytes. J. Immunol. 173: 340-348 [Abstract] [Full Text]  
  • Xi, H., Kersh, G. J. (2004). Early Growth Response Gene 3 Regulates Thymocyte Proliferation during the Transition from CD4-CD8- to CD4+CD8+1. J. Immunol. 172: 964-971 [Abstract] [Full Text]  
  • Pardo, J., Buferne, M., Martinez-Lorenzo, M.-J., Naval, J., Schmitt-Verhulst, A.-M., Boyer, C., Anel, A. (2003). Differential implication of protein kinase C isoforms in cytotoxic T lymphocyte degranulation and TCR-induced Fas ligand expression. Int Immunol 15: 1441-1450 [Abstract] [Full Text]  
  • Droin, N. M., Pinkoski, M. J., Dejardin, E., Green, D. R. (2003). Egr Family Members Regulate Nonlymphoid Expression of Fas Ligand, TRAIL, and Tumor Necrosis Factor during Immune Responses. Mol. Cell. Biol. 23: 7638-7647 [Abstract] [Full Text]  
  • Gerber, D. J., Hall, D., Miyakawa, T., Demars, S., Gogos, J. A., Karayiorgou, M., Tonegawa, S. (2003). Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc. Natl. Acad. Sci. USA 100: 8993-8998 [Abstract] [Full Text]  
  • Cippitelli, M., Fionda, C., Di Bona, D., Lupo, A., Piccoli, M., Frati, L., Santoni, A. (2003). The Cyclopentenone-Type Prostaglandin 15-Deoxy-{Delta}12,14-Prostaglandin J2 Inhibits CD95 Ligand Gene Expression in T Lymphocytes: Interference with Promoter Activation Via Peroxisome Proliferator-Activated Receptor-{gamma}-Independent Mechanisms. J. Immunol. 170: 4578-4592 [Abstract] [Full Text]  
  • Wu, J., Metz, C., Xu, X., Abe, R., Gibson, A. W., Edberg, J. C., Cooke, J., Xie, F., Cooper, G. S., Kimberly, R. P. (2003). A Novel Polymorphic CAAT/Enhancer-Binding Protein {beta} Element in the FasL Gene Promoter Alters Fas Ligand Expression: A Candidate Background Gene in African American Systemic Lupus Erythematosus Patients. J. Immunol. 170: 132-138 [Abstract] [Full Text]  
  • Chaudhry, S., Freebern, W. J., Smith, J. L., Butscher, W. G., Haggerty, C. M., Gardner, K. (2002). Cross-Regulation of T Cell Growth Factor Expression by p53 and the Tax Oncogene. J. Immunol. 169: 6767-6778 [Abstract] [Full Text]  
  • Kavurma, M. M., Bobryshev, Y., Khachigian, L. M. (2002). Ets-1 Positively Regulates Fas Ligand Transcription via Cooperative Interactions with Sp1. J. Biol. Chem. 277: 36244-36252 [Abstract] [Full Text]  
  • Li, L., Qi, X., Williams, M., Shi, Y., Keegan, A. D. (2002). Overexpression of Insulin Receptor Substrate-1, But Not Insulin Receptor Substrate-2, Protects a T Cell Hybridoma from Activation-Induced Cell Death. J. Immunol. 168: 6215-6223 [Abstract] [Full Text]  
  • Yang, Y., Dong, B., Mittelstadt, P. R., Xiao, H., Ashwell, J. D. (2002). HIV Tat Binds Egr Proteins and Enhances Egr-dependent Transactivation of the Fas Ligand Promoter. J. Biol. Chem. 277: 19482-19487 [Abstract] [Full Text]  
  • Ise, W., Totsuka, M., Sogawa, Y., Ametani, A., Hachimura, S., Sato, T., Kumagai, Y., Habu, S., Kaminogawa, S. (2002). Naive CD4+ T Cells Exhibit Distinct Expression Patterns of Cytokines and Cell Surface Molecules on Their Primary Responses to Varying Doses of Antigen. J. Immunol. 168: 3242-3250 [Abstract] [Full Text]  
  • Miller, A. T., Berg, L. J. (2002). Defective Fas Ligand Expression and Activation-Induced Cell Death in the Absence of IL-2-Inducible T Cell Kinase. J. Immunol. 168: 2163-2172 [Abstract] [Full Text]  
  • Cippitelli, M., Fionda, C., Di Bona, D., Di Rosa, F., Lupo, A., Piccoli, M., Frati, L., Santoni, A. (2002). Negative Regulation of CD95 Ligand Gene Expression by Vitamin D3 in T Lymphocytes. J. Immunol. 168: 1154-1166 [Abstract] [Full Text]  
  • Kirchhoff, S., Sebens, T., Baumann, S., Krueger, A., Zawatzky, R., Li-Weber, M., Meinl, E., Neipel, F., Fleckenstein, B., Krammer, P. H. (2002). Viral IFN-Regulatory Factors Inhibit Activation-Induced Cell Death Via Two Positive Regulatory IFN-Regulatory Factor 1-Dependent Domains in the CD95 Ligand Promoter. J. Immunol. 168: 1226-1234 [Abstract] [Full Text]  
  • Devadas, S., Zaritskaya, L., Rhee, S. G., Oberley, L., Williams, M. S. (2002). Discrete Generation of Superoxide and Hydrogen Peroxide by T Cell Receptor Stimulation: Selective Regulation of Mitogen-Activated Protein Kinase Activation and Fas Ligand Expression. JEM 195: 59-70 [Abstract] [Full Text]  
  • Wasem, C., Frutschi, C., Arnold, D., Vallan, C., Lin, T., Green, D. R., Mueller, C., Brunner, T. (2001). Accumulation and Activation-Induced Release of Preformed Fas (CD95) Ligand During the Pathogenesis of Experimental Graft-Versus-Host Disease. J. Immunol. 167: 2936-2941 [Abstract] [Full Text]  
  • Ayroldi, E., Migliorati, G., Bruscoli, S., Marchetti, C., Zollo, O., Cannarile, L., D'Adamio, F., Riccardi, C. (2001). Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor {kappa}B. Blood 98: 743-753 [Abstract] [Full Text]  
  • Roger, J., Chalifour, A., Lemieux, S., Duplay, P. (2001). Cutting Edge: Ly49A Inhibits TCR/CD3-Induced Apoptosis and IL-2 Secretion. J. Immunol. 167: 6-10 [Abstract] [Full Text]  
  • Steff, A.-M., Trop, S., Maira, M., Drouin, J., Hugo, P. (2001). Opposite Ability of Pre-TCR and {{alpha}}{{beta}}TCR to Induce Apoptosis. J. Immunol. 166: 5044-5050 [Abstract] [Full Text]  
  • Dzialo-Hatton, R., Milbrandt, J., Hockett, R. D. Jr., Weaver, C. T. (2001). Differential Expression of Fas Ligand in Th1 and Th2 Cells Is Regulated by Early Growth Response Gene and NF-AT Family Members. J. Immunol. 166: 4534-4542 [Abstract] [Full Text]  
  • Lindgren, H., Axcrona, K., Leanderson, T. (2001). Regulation of Transcriptional Activity of the Murine CD40 Ligand Promoter in Response to Signals Through TCR and the Costimulatory Molecules CD28 and CD2. J. Immunol. 166: 4578-4585 [Abstract] [Full Text]  
  • Gourley, T. S., Chang, C.-H. (2001). Cutting Edge: The Class II Transactivator Prevents Activation-Induced Cell Death by Inhibiting Fas Ligand Gene Expression. J. Immunol. 166: 2917-2921 [Abstract] [Full Text]  
  • Wang, R., Zhang, L., Zhang, X., Moreno, J., Luo, X., Tondravi, M., Shi, Y. (2001). Differential Regulation of the Expression of CD95 Ligand, Receptor Activator of Nuclear Factor-{{kappa}}B Ligand (RANKL), TNF-Related Apoptosis-Inducing Ligand (TRAIL), and TNF-{{alpha}} During T Cell Activation. J. Immunol. 166: 1983-1990 [Abstract] [Full Text]  
  • Delgado, M., Ganea, D. (2001). Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide Inhibit Expression of Fas Ligand in Activated T Lymphocytes by Regulating c-Myc, NF-{{kappa}}B, NF-AT, and Early Growth Factors 2/3. J. Immunol. 166: 1028-1040 [Abstract] [Full Text]  
  • Norian, L. A., Latinis, K. M., Eliason, S. L., Lyson, K., Yang, C., Ratliff, T., Koretzky, G. A. (2000). The Regulation of CD95 (Fas) Ligand Expression in Primary T Cells: Induction of Promoter Activation in CD95LP-Luc Transgenic Mice. J. Immunol. 164: 4471-4480 [Abstract] [Full Text]  
  • Chow, W. A., Fang, J. J., Yee, J.-K. (2000). The IFN Regulatory Factor Family Participates in Regulation of Fas Ligand Gene Expression in T Cells. J. Immunol. 164: 3512-3518 [Abstract] [Full Text]  
  • Sevetson, B. R., Svaren, J., Milbrandt, J. (2000). A Novel Activation Function for NAB Proteins in EGR-dependent Transcription of the Luteinizing Hormone beta Gene. J. Biol. Chem. 275: 9749-9757 [Abstract] [Full Text]  
  • Zhang, J., Gao, J.-X., Salojin, K., Shao, Q., Grattan, M., Meagher, C., Laird, D. W., Delovitch, T. L. (2000). Regulation of FAS Ligand Expression during Activation-Induced Cell Death in T Cells by p38 Mitogen-Activated Protein Kinase and C-Jun Nh2-Terminal Kinase. JEM 191: 1017-1030 [Abstract] [Full Text]  
  • Matsui, K., Xiao, S., Fine, A., Ju, S.-T. (2000). Role of Activator Protein-1 in TCR-Mediated Regulation of the Murine fasl Promoter. J. Immunol. 164: 3002-3008 [Abstract] [Full Text]  
  • Aoudjit, F., Vuori, K. (2000). Engagement of the alpha 2beta 1 integrin inhibits Fas ligand expression and activation-induced cell death in T cells in a focal adhesion kinase-dependent manner. Blood 95: 2044-2051 [Abstract] [Full Text]  
  • Li, X. R., Chong, A. S.-F., Wu, J., Roebuck, K. A., Kumar, A., Parrillo, J. E., Rapp, U. R., Kimberly, R. P., Williams, J. W., Xu, X. (1999). Transcriptional Regulation of Fas Gene Expression by GA-binding Protein and AP-1 in T Cell Antigen Receptor{middle dot}CD3 Complex-stimulated T Cells. J. Biol. Chem. 274: 35203-35210 [Abstract] [Full Text]  
  • Zhang, J., Ma, B., Marshak-Rothstein, A., Fine, A. (1999). Characterization of a Novel Cis-element That Regulates Fas Ligand Expression in Corneal Endothelial Cells. J. Biol. Chem. 274: 26537-26542 [Abstract] [Full Text]  
  • Milner, J. D., Kent, S. C., Ashley, T. A., Wilson, S. B., Strominger, J. L., Hafler, D. A. (1999). Differential Responses of Invariant V{alpha}24J{alpha}Q T Cells and MHC Class II-Restricted CD4+ T Cells to Dexamethasone. J. Immunol. 163: 2522-2529 [Abstract] [Full Text]  
  • Pratt, J. C., van den Brink, M. R. M., Igras, V. E., Walk, S. F., Ravichandran, K. S., Burakoff, S. J. (1999). Requirement for Shc in TCR-Mediated Activation of a T Cell Hybridoma. J. Immunol. 163: 2586-2591 [Abstract] [Full Text]  
  • O'Donovan, K. J., Baraban, J. M. (1999). Major Egr3 Isoforms Are Generated via Alternate Translation Start Sites and Differ in Their Abilities To Activate Transcription. Mol. Cell. Biol. 19: 4711-4718 [Abstract] [Full Text]  
  • Ivanov, V. N., Ronai, Z.'e. (1999). Down-regulation of Tumor Necrosis Factor alpha  Expression by Activating Transcription Factor 2 Increases UVC-induced Apoptosis of Late-stage Melanoma Cells. J. Biol. Chem. 274: 14079-14089 [Abstract] [Full Text]  
  • Mittelstadt, P. R., Ashwell, J. D. (1999). Role of Egr-2 in Up-regulation of Fas Ligand in Normal T Cells and Aberrant Double-negative lpr and gld T Cells. J. Biol. Chem. 274: 3222-3227 [Abstract] [Full Text]  
  • Mittelstadt, P. R., Ashwell, J. D. (2001). Inhibition of AP-1 by the Glucocorticoid-inducible Protein GILZ. J. Biol. Chem. 276: 29603-29610 [Abstract] [Full Text]